ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1845

Immune Cell Profiles and Transcriptomic Signatures of Atherosclerosis in Systemic Lupus Erythemathosus

Rodolfo Martinez-Canales1, Andres M. Ortiz-Rios2, Braulio R. Avalos-Garcia2, Eva Abigaid Galindo-Calvillo2, Mario Cesar Salinas-Carmona1, Noe Macias-Segura1, Lorena Perez-Barbosa2, Dionicio A. Galarza-Delgado3 and Cassandra Michele Skinner-Taylor2, 1Immunology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

Meeting: ACR Convergence 2025

Keywords: Atherosclerosis, Biomarkers, Gene Expression, immunology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1830–1854) Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) significantly increases the risk of premature atherosclerosis, contributing to long-term morbidity and mortality. Traditional cardiovascular risk factors do not fully explain this phenomenon. Immunologically driven endothelial injury is proposed as a key mechanism. This study integrates transcriptomic and immune cell profiling data to identify molecular and cellular signatures associated with subclinical atherosclerosis in SLE.

Methods: Transcriptomic datasets GSE154851 and GSE110174 were obtained from the Gene Expression Omnibus. GSE154851 includes patients with increased carotid intima-media thickness (CIMT), while GSE110174 includes SLE patients without CIMT and healthy controls. Gene set enrichment analysis (GSEA) was conducted to identify genes linked to coronary atherosclerosis. Protein-protein interaction (PPI) networks were analyzed using Cytoscape, with hub genes (HGs) identified through five centrality algorithms. Immune cell fractions (22 types) were estimated via CIBERSORTx. A two-way ANOVA with FDR correction was used to compare cell populations across groups, and logistic regression assessed associations with CIMT status.

Results: Nineteen genes were significantly enriched in the atherosclerosis phenotype, including ACTA2, ABCA1, MYH11, APOB, PCSK9, PPARG, TGFBR1, and SMAD3. Immune cell profiling revealed significant differences in CD8+ T cells, CD4+ naïve and memory subsets, NK cells, monocytes, M0 macrophages, and neutrophils. CD8+ T cells, CD4+ naïve T cells, and resting NK cells were negatively associated with CIMT, whereas CD4+ memory resting T cells, monocytes, and M0 macrophages showed positive associations (all p < 0.001). Diagnostic accuracy was supported by ROC curve analysis, highlighting monocytes and CD4+ memory T cells as potential biomarkers.

Conclusion: This study uncovers specific immune cell subsets and gene networks linked to atherosclerosis in SLE. The findings emphasize the contribution of innate and adaptive immune dysregulation in vascular pathology and support further exploration of immune-based biomarkers to stratify cardiovascular risk in lupus.

Supporting image 1Figure 1. Immune profiling and diagnostic relevance of hub genes in SLE-related atherosclerosis. (a) Gene set enrichment analysis of transcripts linked to coronary atherosclerosis in individuals with systemic lupus erythematosus (SLE). (b) Common hub genes determined by the intersection of five centrality-based algorithms. (c) Relative abundance of 22 immune cell subsets in healthy controls (HC), SLE patients without carotid intima-media thickening (CIMT), and SLE patients with increased CIMT (SLEat). (d) Receiver operating characteristic (ROC) curves showing the predictive performance of monocyte counts and resting CD4+ memory T cells for identifying subclinical atherosclerosis in the SLE cohort.

Supporting image 2


Disclosures: R. Martinez-Canales: None; A. Ortiz-Rios: None; B. Avalos-Garcia: None; E. Galindo-Calvillo: None; M. Salinas-Carmona: None; N. Macias-Segura: None; L. Perez-Barbosa: None; D. Galarza-Delgado: None; C. Skinner-Taylor: None.

To cite this abstract in AMA style:

Martinez-Canales R, Ortiz-Rios A, Avalos-Garcia B, Galindo-Calvillo E, Salinas-Carmona M, Macias-Segura N, Perez-Barbosa L, Galarza-Delgado D, Skinner-Taylor C. Immune Cell Profiles and Transcriptomic Signatures of Atherosclerosis in Systemic Lupus Erythemathosus [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/immune-cell-profiles-and-transcriptomic-signatures-of-atherosclerosis-in-systemic-lupus-erythemathosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immune-cell-profiles-and-transcriptomic-signatures-of-atherosclerosis-in-systemic-lupus-erythemathosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology